Implantation of Impella CP left ventricular assist device under the guidance of three-dimensional intracardiac echocardiography

Impella CP is a percutaneously inserted left ventricular assist device indicated for temporary mechanical cardiac support during high risk percutaneous coronary interventions and for cardiogenic shock. The potential application of Impella has become particularly relevant during the current COVID-19...

Full description

Saved in:
Bibliographic Details
Published in:Scientific reports 2020-10, Vol.10 (1), p.17485-17485, Article 17485
Main Authors: Yastrebov, Konstantin, Brunel, Laurencie, Paterson, Hugh S., Williams, Zoe A., Wise, Innes K., Burrows, Christopher S., Bannon, Paul G.
Format: Article
Language:English
Subjects:
692/308/575
692/4019/2773
Animals
Aortic Valve - diagnostic imaging
Aortic Valve - physiology
Betacoronavirus - isolation & purification
Congestive heart failure
Coronavirus Infections - complications
Coronavirus Infections - pathology
Coronavirus Infections - virology
COVID-19
Disease Models, Animal
Echocardiography
Epidemiology
Female
Fluoroscopy
Heart Failure - complications
Heart Failure - therapy
Heart-Assist Devices
Humanities and Social Sciences
Imaging, Three-Dimensional
multidisciplinary
Pandemics
Patients
Pneumonia, Viral - complications
Pneumonia, Viral - pathology
Pneumonia, Viral - virology
Prostheses and Implants
SARS-CoV-2
Science
Science (multidisciplinary)
Sheep
Ultrasonography, Doppler
Ventricle
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Impella CP is a percutaneously inserted left ventricular assist device indicated for temporary mechanical cardiac support during high risk percutaneous coronary interventions and for cardiogenic shock. The potential application of Impella has become particularly relevant during the current COVID-19 pandemic, for patients with acute severe heart failure complicating viral illness. Standard implantation of the Impella CP is performed under fluoroscopic guidance. Positioning of the Impella CP can be confirmed with transthoracic or transoesophageal echocardiography. We describe an alternative approach to guide intracardiac implantation of the Impella CP using two-dimensional and three-dimensional intracardiac echocardiography. This new technique can be useful in selected groups of patients when fluoroscopy, transthoracic and transoesophageal echocardiography is deemed inapplicable or limited for epidemiological or clinical reasons. Intracardiac three-dimensional echocardiography is a feasible alternative to the traditional techniques for implantation of an Impella CP device but careful consideration must be given to the potential limitations and complications of this technique.
ISSN:2045-2322
2045-2322
DOI:10.1038/s41598-020-74220-8